FDA
approval
· 2021-04-28
FDA Approved: TREXIMET — Supplemental Application (Currax Pharmaceuticals LLC)
Summary
The FDA approved a supplemental application for TREXIMET (sumatriptan succinate and naproxen sodium) from Currax Pharmaceuticals LLC. This action authorizes the…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TREXIMET (SUMATRIPTAN SUCCINATE AND NAPROXEN SODIUM)